http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2726119-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ea46551e141c1b71064d0cb4ae10877
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
filingDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5e8bcdf5820c33a8af3f07fc4f538d
publicationDate 2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2726119-C1
titleOfInvention Novel derivatives of polyols, use thereof, a pharmaceutical composition based thereon
abstract FIELD: chemistry. n SUBSTANCE: invention relates to a novel compound of general formula (I) and a pharmaceutically acceptable salt thereof of general formula (I). Compounds can be used for treating and / or preventing respiratory diseases selected from a group consisting of rhinitis, sinusitis, rhinosinusitis, pharyngitis, nasopharyngitis, tonsillitis, vocal folds and larynx diseases, vasomotor and allergic rhinitis, bronchitis, bronchiolitis, pneumonia, bronchial asthma, chronic obstructive pulmonary disease, cystic fibrosis. In particular, the compounds can be used for treating and / or preventing viral infection mediated diseases, such as rhinovirus, respiratory syncytial virus, parainfluenza virus, influenza virus, adenovirus, metapneumovirus, coronavirus, Coxsackie virus, enterovirus, rotavirus, herpes virus. In general formula (I) n (I) n at least one of R is . n EFFECT: compounds have antiviral and anti-inflammatory activity. n 8 cl, 4 dwg, 5 tbl, 2 ex
priorityDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2628800-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-030188-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414816610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46932227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468172510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453018404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9812759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423325666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21924354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410490416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671614

Total number of triples: 42.